CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model
BackgroundThe prognosis of patients with hepatocellular carcinoma (HCC) is a research hotspot. This study aimed to identify novel prognostic protein markers for HCC using data-independent acquisition mass spectrometry (DIA-MS) and develop an integrative predictive model to enhance clinical decision-...
Saved in:
| Main Authors: | Qiulong Lu, Zhao Cao, Yueting Xiong, Junqiang Huang, Huan Zeng, Zhijian Chen, You Shu, Yahan Tan, Xiaoling Long, Xiaohui Liu, Hong Shu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1577161/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PLOD3 as a novel oncogene in prognostic and immune infiltration risk model based on multi-machine learning in cervical cancer
by: Lingling Qiu, et al.
Published: (2025-03-01) -
Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis
by: Feixiang Wu, et al.
Published: (2025-07-01) -
Identification and validation of CKAP2 as a novel biomarker in the development and progression of rheumatoid arthritis
by: Qiongbing Zheng, et al.
Published: (2025-06-01) -
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
by: Sebastian Virreira Winter, et al.
Published: (2021-01-01) -
Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma
by: Jia‐Hao Law, et al.
Published: (2025-08-01)